ALT-15.83%7.7%
ARQT+76.43%7.7%
ARWR+432.86%7.7%
AVXL-70.83%7.7%
BCRX+5.47%7.7%
BHVN-9.50%7.7%
HALO+34.13%7.7%
KNSA+138.63%7.7%
KROS-30.64%7.7%
KYMR+155.09%7.7%
SPRY-70.19%7.7%
TERN+45.68%7.7%
VRDN+22.50%7.7%
As of Aug 6, 2026, 4:25 AM ET
Biotech '24: Pharma/Therapeutics Constituents
Altimmune, Inc.ALT | 7.7% | -1.30% | 9.39% | -1.62% | 6.69% | -16.07% | -29.70% | -36.61% | -15.83% | $267.4M |
Anavex Life Sciences Corp.AVXL | 7.7% | 1.59% | 33.33% | 20.30% | 16.36% | -10.11% | -27.77% | -62.62% | -70.83% | $296.5M |
Arcutis Biotherapeutics, Inc.ARQT | 7.7% | 4.11% | -0.91% | 3.95% | 0.89% | -6.68% | 0.48% | 63.25% | 76.43% | $3.39B |
Arrowhead Pharmaceuticals, Inc.ARWR | 7.7% | -2.99% | 1.53% | 0.42% | 2.67% | 30.91% | 37.36% | 584.87% | 432.86% | $12.24B |
ARS Pharmaceuticals, Inc.SPRY | 7.7% | 0.75% | -9.76% | -35.65% | 4.48% | -53.99% | -42.24% | -58.93% | -70.19% | $532.3M |
BioCryst Pharmaceuticals, Inc.BCRX | 7.7% | 0.55% | -2.89% | -10.82% | 1.00% | 16.28% | 3.66% | 22.07% | 5.47% | $2.31B |
Biohaven Ltd.BHVN | 7.7% | -0.87% | -4.82% | -15.08% | 0.96% | 20.73% | 18.32% | -42.44% | -9.50% | $2.05B |
Halozyme Therapeutics, Inc.HALO | 7.7% | 0.43% | 2.03% | 3.48% | 1.27% | 24.21% | 20.22% | 32.64% | 34.13% | $9.91B |
Keros Therapeutics, Inc.KROS | 7.7% | -2.49% | -0.65% | -9.38% | -0.74% | -50.91% | -29.56% | -0.45% | -30.64% | $319.8M |
Kiniksa Pharmaceuticals International, plcKNSA | 7.7% | 2.75% | 24.25% | 24.39% | 5.03% | 89.28% | 75.50% | 257.35% | 138.63% | $5.87B |
Kymera Therapeutics, Inc.KYMR | 7.7% | 1.04% | -4.60% | -8.09% | 2.01% | 35.56% | 15.47% | 300.15% | 155.09% | $8.68B |
Terns Pharmaceuticals, Inc.TERN | 7.7% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 231.73% | 45.68% | $744.0M |
Viridian Therapeutics, Inc.VRDN | 7.7% | 1.10% | 9.34% | 10.95% | 11.36% | -32.29% | -28.28% | 61.21% | 22.50% | $1.90B |
| Theme return | — | 0.36% | 4.33% | -1.60% | 4.35% | 5.39% | 2.99% | 76.34% | 34.82% | — |
| Average | 7.7% | 0.36% | 4.33% | -1.32% | 4.00% | 3.61% | 1.04% | 104.02% | 54.91% | $3.73B |
| Median | 7.7% | 0.55% | 0.00% | 0.00% | 2.01% | 0.00% | 0.48% | 32.64% | 22.50% | $2.05B |
| Std Dev | 0.0% | 1.89% | 11.72% | 14.94% | 4.76% | 37.47% | 31.85% | 182.14% | 127.79% | $3.95B |
| Min | 7.7% | -2.99% | -9.76% | -35.65% | -0.74% | -53.99% | -42.24% | -62.62% | -70.83% | $267.4M |
| Max | 7.7% | 4.11% | 33.33% | 24.39% | 16.36% | 89.28% | 75.50% | 584.87% | 432.86% | $12.24B |
| % Positive Tickers | 61.54% | 46.15% | 46.15% | 84.62% | 46.15% | 53.85% | 61.54% | 61.54% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Biotech '24: Pharma/Therapeutics tracks 13 publicly listed stocks in this theme. Sample tickers: ALT, ARQT, ARWR, AVXL, BCRX, BHVN, HALO, KNSA, KROS, KYMR, SPRY, TERN, and 1 more. Use the table below for the full list.